In mortality studies of patients after acute myocardial infarction (AMI), exclusion of patients
during selection from the screened population may be imporlant for evaluating the impact of …

Abstract The TRAndolapril Cardiac Evaluation (TRACE) study is evaluating the effect of
angiotensin-converting enzyme inhibition with trandolapril on mortality (overall and …

Background Treatment with angiotensin-converting–enzyme (ACE) inhibitors reduces
mortality among survivors of acute myocardial infarction, but whether to use ACE inhibitors …

Aims To investigate the long-term benefits of treatment with angiotensin-converting enzyme
(ACE)-inhibitors in patients with myocardial infarction (MI) and left ventricular dysfunction …

To study the importance of giving an angiotensin-converting enzyme (ACE) inhibitor to
patients with reduced systolic function after an infarction, the Trandodolapril Cardiac …

BACKGROUND: The causes of death occurring in clinical trials of myocardial infarction (MI)
are scarcely reported in the literature. The present analysis is aimed to describe the …

The aim of this study was to assess the importance of congestive heart failure and left
ventricular (LV) systolic dysfunction after an acute myocardial infarction (AMI) on long-term …

Objective To evaluate the influence of a history of arterial hypertension on the efficacy of the
angiotensin converting enzyme (ACE) inhibitor trandolapril in patients with acute myocardial …

Few studies have investigated whether angiotensin II receptor blocker (ARB) is a practical
alternative to angiotensin-converting enzyme inhibitor (ACEI) for long-term use after acute …

What is already known about this subject• Treatment with an angiotensin‐converting
enzyme (ACE) inhibitor benefits many patients with cardiovascular disease.• ACE inhibitors …